Tycel Phillips
-
- Lymphoma Diagnosis and Treatment 123
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 83
- Oncology top 5%
- CAR-T cell therapy research 42
- Viral-associated cancers and disorders 17
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 9
- Immunology top 10%
-
- Cutaneous lymphoproliferative disorders research 19
-
- Monoclonal and Polyclonal Antibodies Research 16
-
- CNS Lymphoma Diagnosis and Treatment 8
- Co-authors
- Ryan A. WilcoxSumana DevataMark KaminskiMoshe TalpazPhilip S. BoonstraPaul M. BarrVincent RibragJavier Muñoz
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Tycel Phillips
139 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 72
- Pathology and Forensic Medicine 956
- Genetics 554
- Oncology 899
- Hematology 278
- Immunology 367
Countries citing papers authored by Tycel Phillips
This map shows the geographic impact of Tycel Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tycel Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tycel Phillips more than expected).
Fields of papers citing papers by Tycel Phillips
This network shows the impact of papers produced by Tycel Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tycel Phillips. The network helps show where Tycel Phillips may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tycel Phillips, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 20 | |
| 16 | 2020 | 37 | |
| 17 | 2020 | 16 | |
| 18 | 2019 | 15 | |
| 19 | 2017 | 2 | |
| 20 | 1971 | 7 |
About Tycel Phillips
Tycel Phillips is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Dermatology and Hematology, having authored 149 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (123 papers), Chronic Lymphocytic Leukemia Research (83 papers), CAR-T cell therapy research (42 papers), Cutaneous lymphoproliferative disorders research (19 papers), Viral-associated cancers and disorders (17 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Chronic Myeloid Leukemia Treatments (9 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (956 citations), Genetics (554 citations), Oncology (899 citations), Hematology (278 citations) and Immunology (367 citations). Tycel Phillips has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Ryan A. Wilcox, Sumana Devata, Mark Kaminski, Moshe Talpaz, Philip S. Boonstra, Paul M. Barr, Vincent Ribrag, Javier Muñoz, Paula Bockenstedt and Samuel A. Merrill. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Hematological Oncology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.